Citrate anticoagulation versus systemic heparinisation in continuous venovenous hemofiltration in critically ill patients with acute kidney injury: a multi-center randomized clinical trial

Clicks: 281
ID: 270472
2014
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Steady

Ranked #11 of 17 articles by views in critical care

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Abstract
Because of ongoing controversy, renal and vital outcomes are compared between systemically administered unfractionated heparin and regional anticoagulation with citrate-buffered replacement solution in predilution mode, during continuous venovenous hemofiltration ...
Reference Key
group2014criticalcitrate Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Louise Schilder, S Azam Nurmohamed, Frank H Bosch, Ilse M Purmer, Sylvia S den Boer, Cynthia G Kleppe, Marc G Vervloet, Albertus Beishuizen, Armand RJ Girbes, Pieter M ter Wee, AB Johan Groeneveld, for the CASH study group;Louise Schilder;S Azam Nurmohamed;Frank H Bosch;Ilse M Purmer;Sylvia S den Boer;Cynthia G Kleppe;Marc G Vervloet;Albertus Beishuizen;Armand RJ Girbes;Pieter M ter Wee;AB Johan Groeneveld;for the CASH study group;
Journal critical care
Year 2014
DOI
10.1186/s13054-014-0472-6
URL
Keywords

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

No comments yet. Be the first to comment on this article.